Receptors, CXCR3

"Receptors, CXCR3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

CXCR receptors that are expressed on the surface of a number of cell types, including T-LYMPHOCYTES; NK CELLS; DENDRITIC CELLS; and a subset of B-LYMPHOCYTES. The receptors are activated by CHEMOKINE CXCL9; CHEMOKINE CXCL10; and CHEMOKINE CXCL11.

Descriptor ID	D054367
MeSH Number(s)	D12.776.543.750.695.160.500.300 D12.776.543.750.705.852.125.500.300
Concept/Terms	Receptors, CXCR3 Receptors, CXCR3 CXCR3 Receptor Receptor, CXCR3 CXC Chemokine Receptor 3 CD183 Antigens Antigens, CD183 CXCR3 Receptors Chemokine (C-C Motif) Receptor 3 CMKBR3 Chemokine Receptors Chemokine Receptors, CMKBR3 Receptors, CMKBR3 Chemokine CXC Chemokine Receptors 3

Below are MeSH descriptors whose meaning is more general than "Receptors, CXCR3".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, G-Protein-Coupled [D12.776.543.750.695]
Receptors, Chemokine [D12.776.543.750.695.160]
Receptors, CXCR [D12.776.543.750.695.160.500]
Receptors, CXCR3 [D12.776.543.750.695.160.500.300]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Cytokine [D12.776.543.750.705.852]
Receptors, Chemokine [D12.776.543.750.705.852.125]
Receptors, CXCR [D12.776.543.750.705.852.125.500]
Receptors, CXCR3 [D12.776.543.750.705.852.125.500.300]

Below are MeSH descriptors whose meaning is related to "Receptors, CXCR3".

Below are MeSH descriptors whose meaning is more specific than "Receptors, CXCR3".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, CXCR3" by people in this website by year, and whether "Receptors, CXCR3" was a major or minor topic of these publications.

Bar chart showing 10 publications over 9 distinct years, with a maximum of 2 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2003	0	1	1
2006	0	1	1
2008	1	0	1
2009	1	0	1
2011	1	0	1
2017	1	0	1
2018	0	1	1
2024	0	2	2

Below are the most recent publications written about "Receptors, CXCR3" by people in Profiles.

McCord JL, Han JYS, Staudt RE, Philp NJ, Snyder CM. Immune responses drive chorioretinitis and retinal pathology after neonatal CMV infection. Sci Adv. 2024 11 22; 10(47):eadn6379.

View in: PubMed
Burton RJ, Raffray L, Moet LM, Cuff SM, White DA, Baker SE, Moser B, O'Donnell VB, Ghazal P, Morgan MP, Artemiou A, Eberl M. Conventional and unconventional T-cell responses contribute to the prediction of clinical outcome and causative bacterial pathogen in sepsis patients. Clin Exp Immunol. 2024 May 16; 216(3):293-306.

View in: PubMed
Wong E, Xu RH, Rubio D, Lev A, Stotesbury C, Fang M, Sigal LJ. Migratory Dendritic Cells, Group 1 Innate Lymphoid Cells, and Inflammatory Monocytes Collaborate to Recruit NK Cells to the Virus-Infected Lymph Node. Cell Rep. 2018 07 03; 24(1):142-154.

View in: PubMed
Caldeira-Dantas S, Furmanak T, Smith C, Quinn M, Teos LY, Ertel A, Kurup D, Tandon M, Alevizos I, Snyder CM. The Chemokine Receptor CXCR3 Promotes CD8+ T Cell Accumulation in Uninfected Salivary Glands but Is Not Necessary after Murine Cytomegalovirus Infection. J Immunol. 2018 02 01; 200(3):1133-1145.

View in: PubMed
Winkler AE, Brotman JJ, Pittman ME, Judd NP, Lewis JS, Schreiber RD, Uppaluri R. CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis. Cancer Res. 2011 Sep 01; 71(17):5707-16.

View in: PubMed
Kelsen SG, Aksoy MO, Georgy M, Hershman R, Ji R, Li X, Hurford M, Solomides C, Chatila W, Kim V. Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3. Am J Respir Crit Care Med. 2009 May 01; 179(9):799-805.

View in: PubMed
Uppaluri R, Sheehan KC, Wang L, Bui JD, Brotman JJ, Lu B, Gerard C, Hancock WW, Schreiber RD. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation. 2008 Jul 15; 86(1):137-47.

View in: PubMed
Fiorina P, Ansari MJ, Jurewicz M, Barry M, Ricchiuti V, Smith RN, Shea S, Means TK, Auchincloss H, Luster AD, Sayegh MH, Abdi R. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol. 2006 Mar; 17(3):716-23.

View in: PubMed
Raju R, Vasconcelos O, Granger R, Dalakas MC. Expression of IFN-gamma-inducible chemokines in inclusion body myositis. J Neuroimmunol. 2003 Aug; 141(1-2):125-31.

View in: PubMed
Hauser AE, Debes GF, Arce S, Cassese G, Hamann A, Radbruch A, Manz RA. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol. 2002 Aug 01; 169(3):1277-82.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement